These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 21569804)

  • 21. Controlling and Monitoring Intracellular Delivery of Anticancer Polymer Nanomedicines.
    Battistella C; Klok HA
    Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28444959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanotechnology: nanomedicine.
    Kenwright K; Pifer LL
    Clin Lab Sci; 2010; 23(2):112-6. PubMed ID: 20499536
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety and Toxicological Considerations of Nanomedicines: The Future Directions.
    Patel P; Shah J
    Curr Clin Pharmacol; 2017; 12(2):73-82. PubMed ID: 28486906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanotechnology-based intelligent drug design for cancer metastasis treatment.
    Gao Y; Xie J; Chen H; Gu S; Zhao R; Shao J; Jia L
    Biotechnol Adv; 2014; 32(4):761-77. PubMed ID: 24211475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming.
    Wang J; Lu Z; Gao Y; Wientjes MG; Au JL
    Nanomedicine (Lond); 2011 Nov; 6(9):1605-20. PubMed ID: 22077464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploiting endocytosis for nanomedicines.
    Akinc A; Battaglia G
    Cold Spring Harb Perspect Biol; 2013 Nov; 5(11):a016980. PubMed ID: 24186069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymeric nanomedicines as a promising vehicle for solid tumor therapy and targeting.
    Gupta M; Agrawal GP; Vyas SP
    Curr Mol Med; 2013 Jan; 13(1):179-204. PubMed ID: 22834834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases.
    Maurya S; Srivastava R; Arfin S; Hawthorne S; Jha NK; Agrawal K; Raj S; Rathi B; Kumar A; Raj R; Agrawal S; Paiva-Santos AC; Malik AA; Dua K; Rana R; Ojha S; Jha SK; Sharma A; Kumar D; El-Zahaby SA; Nagar A
    Nanomedicine (Lond); 2022 Dec; 17(30):2245-2264. PubMed ID: 36975758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
    Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
    Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical developments in nanotechnology for cancer therapy.
    Heidel JD; Davis ME
    Pharm Res; 2011 Feb; 28(2):187-99. PubMed ID: 20549313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanomedicines: promises and reality.
    Lagarce F
    Drug Discov Today; 2020 Mar; 25(3):473-474. PubMed ID: 31978388
    [No Abstract]   [Full Text] [Related]  

  • 34. The Carolina Center of Cancer Nanotechnology Excellence: past accomplishments and future perspectives.
    Juliano RL; Sunnarborg S; DeSimone J; Haroon Z
    Nanomedicine (Lond); 2011 Jan; 6(1):19-24. PubMed ID: 21182415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced materials and nanotechnology for drug delivery.
    Yan L; Yang Y; Zhang W; Chen X
    Adv Mater; 2014 Aug; 26(31):5533-40. PubMed ID: 24449177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanomedicine and drug delivery.
    Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
    Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conference scene: Nanomedicine and nanotoxicology: future prospects and the need for translational factors for the combination of both.
    Günday N; Schneider M
    Nanomedicine (Lond); 2012 Jun; 7(6):811-4. PubMed ID: 22734640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicines for developing cancer nanotherapeutics: from benchtop to bedside and beyond.
    Iqbal J; Abbasi BA; Ahmad R; Mahmood T; Ali B; Khalil AT; Kanwal S; Shah SA; Alam MM; Badshah H; Munir A
    Appl Microbiol Biotechnol; 2018 Nov; 102(22):9449-9470. PubMed ID: 30219952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of nanoscience and nanotechnology on controlled drug delivery.
    Youan BB
    Nanomedicine (Lond); 2008 Aug; 3(4):401-6. PubMed ID: 18694301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.